GT-032 Belapectin Hepatic Impairment

Clinical trial NCT04332432 · COMPLETED

Trial details

NCT number: NCT04332432
Sponsor: Galectin Therapeutics Inc.
Status: COMPLETED
Phase: Phase 1
Study type: INTERVENTIONAL

Hepatic Impairment

Start date: 2020-06-16
Primary completion: 2022-03-09
Enrollment: 38

View on ClinicalTrials.gov

Track trials programmatically

Sponsors, conditions and status changes through the Atlas API.